I have attended the NeurOPTIMAL® Research Conference in 2012 and now in 2014.  Because NeurOPTIMAL neurofeedback has advanced the field by no longer diagnosing with a static picture from the past of your brain, (the field uses the QEEG or quantitative brain analysis and this is an extra cost to the client) nor deciding how to work with a particular brain, our own research is unique to how we work.  NeurOPTIMAL reads what is happening on all brainwaves frequencies comprehensively and feeds back to your brain its own electrical patterns. Essentially, your brain feeds back to itself, like that of a mirror, what it is about to do and transformation is the natural consequence.  Your brain takes the complete information and improves its own function. Neuroplasticity in action- without having to push or pull it in way that we think is good for it and that cause side effects!
I have seen presentations on how NeurOPTIMAL benefits Alzheimers patients, those with chronic pain, children with fetal alcohol syndrome, those with traumatic brain injuries and concussions, children’s work in school, sleep disorders, cognitive issues and dyslexia, peak performance, those in the performing arts, inflammatory conditions, and much more.
Below are the research and links.
To get a better sense of what clients tell us they receive help with, see the 2008 Independent Survey at this link:



A Family Matter: NeurOptimal® For Fetal Alcohol Syndrome
FAS has a profound impact on both the child and the family. In this pilot study, NeurOptimal® was provided for both child & family members. Standard measures and FMRI were used to assess results.
Dr. Linda Beckett MD
Dr. Janet McCulloch MD
Founders of the Kingston Institute of Psychotherapy & Neurofeedback
In Kingston, Ontario, Canada

ADHD-ADD (Attention Deficit Disorder)

Does NeurOptimal® Neurofeedback Help To Improve Focus/Attention?
A Kid, An Idea, A Study And A Big Payoff
Jules Ford, Founder of OptiMind Neurofeedback, Focus, Clarity, Serenity

Six Case Studies Examining the Effectiveness of a Comprehensive Adaptive Approach to Neurofeedback for Attention Deficit in an Educational Setting
Shannon Warwick, MA
Union Institute and University at Vermont College,Asheville, North Carolina

Effectiveness of EEG Biofeedback as Compared with Methylphenidate in the Treatment of Attention-Deficit/Hyperactivity Disorder: A Clinical Outcome Study
Mohammad Ali Nazari1, Laurent Querne2, Alain De Broca2, Patrick Berquin2
1Department of Psychology, University of Tabriz, Tabriz, Iran; 2Department of Paediatric Neurology, Lab. Neurosciences Fonction- nelles & Pathologies, Amiens, France.


The Latest News on The Continuing Research of Neuroptimal®’s Effects on Alzheimers Patients in France
Daniel Wagner, Zengar NeurOptimal® French Representative & Instructor
Founder of France Neurofeedback NeurOptimum®

Experiences with Alzheimer’s Clients From Referring Hospitals in France

Daniel Wagner, Zengar NeurOptimal® French Representative & Instructor
Founder of France Neurofeedback NeurOptimum®


Effects of NeurOptimal® Neurofeedback on Symptoms of Depression and Anxiety
Dr. Linda Beckett MD
Dr. Janet McCulloch MD
Founders of the Kingston Institute of Psychotherapy & Neurofeedback
In Kingston, Ontario, Canada

Neurofeedback with Anxiety and Affective Disorders
D. Corydon Hammond, PhD, ABEN/ECNS
Physical Medicine and Rehabilitation, University of Utah School of Medicine, PM&R 30 No 1900 East, Salt Lake City, UT 84132-2119, USA

CHEMO BRAIN (Cancer therapy)

The Effect of EEG Biofeedback on Reducing Postcancer Cognitive Impairment
Jean Alvarez, EdD, Fremonta L. Meyer, David L. Granoff and Allan Lundy
Integr Cancer Ther published online 12 April 2013, DOI: 10.1177/1534735413477192
The abstract is available here where the full article is available for purchase.  Alternatively you may email Jean Alvarez directly for a full copy.

Efficacy of EEG Biofeedback in Addressing Cognitive Dysfunction in Cancer Survivors
This study examined the efficacy of EEG biofeedback (neurofeedback) in addressing the cognitive sequelae of cancer therapy, commonly known as “chemobrain” or “chemofog.” Approximately fifty percent of breast cancer survivors exhibit cognitive impairment within three weeks of beginning chemotherapy, and half of those have not recovered one year later.  Neurofeedback, unlike compensatory strategies currently recommended by the National Cancer Institute and major cancer centers, has the potential to restore cognitive function.
Jean Alvarez, EdD, David L. Granoff, Allan Lundy


The Role of NeurOptimal® in Learning:
A program for leaders in family enterprises and the professionals who serve them

NeurOptimal® training is shown to make a difference in an education-training course for professionals as they learn family systems theory. From the capable professionals employed in family firms, managing financial assets, to consulting complicated family enterprises. NeurOptimal® affects the ability to be more of a functioning self in anxious systems.
Kathy Wiseman (Bowen faculty member), Priscilla Friesen & Andrea Maloney Schara, LCSWA

Working With Extrinsic Constraints: 
Clinical Case Study From the Perspective of Bowen Family Systems Theory and NeurOptimal®.
 This study demonstrates the evident changes brought on through NeurOptimal® training
Lois Walker, B.N., M. Div.

Observations of Change in a Family System Using NeurOptimal®
Someone dear to you, someone you deeply care about, has fallen through the cracks in the mental health system.  The medical system has not been able to interrupt a downward spiral in the person’s life. If you are interested in how one person in a family might respond differently in a crisis, you may be interested in this story of how an older sister learns to mange self using family systems theory and NeurOptimal® ( It is a story of learning to be more aware and objective about mental illness and how thoughtful relationships changing, throughout the family, can make a tremendous difference in enabling better functioning (for everyone, not just the symptomatic one). Overall it is a story of how one begins to redirect anxiety in a system.
Andrea Maloney Schara, LCSWA (


Five Year Clinical Outcome Study using NeurOptimal®
Outcome Analysis 2013 using NeurOptimal® Neurofeedback ——– A retrospective chart review
NeurOptimal® neurofeedback is designed to interface with the nervous system as a Non-Linear Complex Dynamical System, whereas traditional ‘evidence based’ research tends to measure linearly.  Therefore, it seems reasonable to measure outcomes because that’s what prospective clients and referral sources really want to know. Since NeurOptimal® is training at the source of complaints, the nervous system’s turbulence, rather than treating diagnostic categories, it also seemed reasonable to look at outcomes across diagnostic categories rather than try to compare medically defined groups where fallible diagnostic judgments create more issues.
Joan Cross, BSc, PT, MPH from the InnerWave Center

Comprehensive Neurofeedback Training in the Context of Psychotherapy for Tranformational Change

A doctoral dissertation submitted to the Dean of Behavioural Health, July 2010.
Karen Cochrane, Ph.D.

Brain-Mind Operational Architectonics Imaging: Technical and Methodological Aspects
Andrew A. Fingelkurts, Alexander A. Fingelkurts
BM-Science – Brain & Mind Technologies Research Centre, P.O. Box 77, FI-02601, Espoo, Finland


The Effects of EEG Neurofeedback and Neuro-Cognitive Processing in the
Educational Environment of an Arts-Based Private Elementary/Middle School
The purpose of this study was to ascertain measurable differences in academic outcomes among two groups of learners within a creative arts curriculum that employed a selfdirected, stress-reduced, and individualized curriculum. One group was provided with EEG neurofeedback and neuro-cognitive coaching for stress reduction, while the other was not. This study measured the rate of improvement in academic progress that a learner can achieve when formalized learning takes place in a stress-reduced arts-based learning environment with EEG neurofeedback and neurocognitive coaching.
Lise’ D. Spurlock-DeLong, Ph.D., CPCRT, CCCM

PTSD (Post Traumatic Stress Disorder)

Overcoming Extreme Challenges: How NeurOptimal® can be an Answer for our Veterans
Marie-Laure Wagner, M.S. Zengar NeurOptimal® Representative & Founder of  InnerOptimal


Natural Sleep Rhythms: From Cells to Behavior  
How NeurOptimal® potentially interfaces with, and restores, natural sleep rhythms.  New evidence mapping cellular networks underlying the brain’s circadian timing nucleus has provided a potential locus of control for the human circadian rhythm (HCR). This network provides a biologically plausible regulatory site for external influence of the HCR-notably pharmacologic agents, environmental influence, and particularly salient to this presentation, NeurOptimal®.
Dr. Ed O’Malley, Ph.D, FAASM (PhD in Neurobiology at Cornell University Graduate School of Medical Sciences; postdoc in EEG brain-mapping and clinical fellowship for board certification in Sleep Medicine (NYU School of Medicine); Director, Norwalk Hospital Sleep Disorders Center for 12 years-pioneered neurofeedback for insomnia).

Optimal Sleep Using NeurOptimal®: Insomnia Studies
Dr. Ed O’Malley, Ph.D, FAASM

Global qEEG Changes Associated With Non-frequency & Non-site Specific Neurofeedback Training
Dr. Ed O’Malley, Ph.D., FAASM  and Merlyn Hurd, PhD, BCIAC/EEG Fellow, New York, NY

Neurofeedback COPD Abstract Submitted by Ed O’Malley PhD, FAASM
Gleeson S, Saad T, Haggerty M, O’Malley M, O’Malley E, Weddle A, Winter S. Efficacy of Neurofeedback as an Adjunct Therapy to Pulmonary Rehabilitation. Am J Respir Crit Care Med, 2009; 179: A2366.

Effectiveness of Neurofeedback Training In Chronic Insomnia
Okunola O,1 O’Malley E,2 O’Malley M2
(1) Norwalk Hospital, Norwalk, Connecticut, Norwalk, CT, USA, (2) Norwalk Hospital, Norwalk, CT, USA

TBI (Traumatic Brain Injury)

A CASE STUDY …. Physical, Psychological and Cognitive Trauma with Recovery through NeurOptimal® Neurofeedback.
Personal case study with pre and post NeurOptimal® psychometric testing and SPECT Scan results.
Denise M. Cull, M.Psych, Forensic

The Use of NeurOptimal® With a Young Adult With an Acute TBI – A Case Study
This is a case study using clinical, NeurOptimal® baseline and anecdotal data. Dr. Lartin’s 22 year old son Brian survived a life-threatening TBI in April of 2012 and had more than 70 sessions of NeurOptimal® in a year. The contribution of NeurOptimal® to his recovery is discussed. Brian made an essentially complete recovery.
Dr. Joan-Marie Lartin, Ph.D., RN and Alan Bachers, Ph.D

NeuroCognitive Approaches to Brain Injury 
Independent case studies focusing on the cognitive aspects of remediation when coupled with NeurOptimal®. 

A trio of case studies, protocols and progress:
1. 24 year old boy with Concussive Syndrome
2. 68 year old woman with primary ischemic stroke
3. 30 month old girl with a rare chromosomal disorder;
Dr. Lise’ D. Spurlock-DeLong, Ph.D., CPCRT, CCCM
Founder of Cognitive Connections, a cognitive rehabilitation clinic focusing on the use of neurofeedback and assistive therapies to promote increased neuroactivity and processing in all people.

Systemic EEG Biofeedback for Traumatic Brain Injury

Since NeurOptimal® helped ChemoBrain patients, will it also help people with TBI with similar symptoms?
Dr. Jean Alvarez, Ed.D
Director of research at the newly incorporated Cleveland-based Applied Brain Research Foundation of Ohio.

“EEG biofeedback meets the AACAP [American Academy of Child and Adolescent Psychiatry] criteria for clinical guideline (CG) for treatment of ADHD, seizure disorders, anxiety (OCD, GAD, PTSD, phobias), depression, reading disabilities, and addictive disorders. This suggests that EEG biofeedback should always be considered as an intervention for these disorders by the clinic.”

  • Hirshberg, L.m., Chiu, S,. Frazier, J, A,. “Emerging brain-based interventions for children and adolescents: overview and clinical perspective.” Child and adolescent psychiatric clinics of North America, 2005, Vol.14(1), pp.1-19
“In my opinion, if any medication had demonstrated such a wide spectrum of efficacy, it would be universally accepted and widely used”
  • Frank H. Duffy, M.D., Professor and Pediatric Neurologist at Harvard Medical School